Home › Therapeutic areas › Hematology › AL Amyloidosis
AL Amyloidosis (4 companies)
Companies with an active program in AL Amyloidosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | 12 |
| FBIO | Fortress Biotech | DermatologyHematology+2 Rare | 1 | Approved | 12 |
| IMMX | Immix Biopharma | Hematology Rare | 1 | Phase 1 | 1 |
| IONS | Ionis Pharmaceuticals | CardiovascularHematology+5 Rare | 2 | Approved | 29 |
No companies match.